摘要
G蛋白偶联受体(GPCRs)是涉及信号转导的细胞膜最大的受体超家族,介导产生多种生理效应,激活相应的信号级联系统,在肝损伤过程中发挥关键作用,是一类非常重要的药物作用靶标。该文就肾上腺素受体、血管紧张素受体、趋化因子受体、蛋白酶激活受体等参与急慢性肝损伤调节的GPCRs相关研究进展做一综述。
The G protein-coupled receptors( GPCRs) superfamily,represents the largest class of molecules involved in signal transduction across the plasma membrane. GPCRs regulate physiological responses to a diverse array of stimuli and mediate multiple physiological processes.As a consequence of this,the potential of GPCRs-based therapeutics being used for liver damage is highlighted. Therefore,this article summarizes the role of GPCRs( including adrenergic receptor, angiotensin receptor,chemokine receptor and endothelin receptor) in acute-and chronic-liver injury.
作者
孙家昌
孙妩弋
厉歆然
彭文婷
魏伟
SUN Jia-chang;SUN Wu-yi;LI Xin-ran;PENG Wen-ting;WEI Wei(Institute of Clinical Pharmacology/Key Laboratory of Anti - inflammatory and Immune Medicine, Ministry of Education/ Collaborative Innovation Center of Anti - inflarmnatory and Immune Medicines, Anhui Medical University, Hefei 230032, Chin)
出处
《中国临床药理学杂志》
CAS
CSCD
北大核心
2018年第8期1000-1004,共5页
The Chinese Journal of Clinical Pharmacology
基金
国家自然科学基金资助项目(81770605
81300332)
关键词
G蛋白偶联受体
肝损伤
信号转导
G protein coupled receptor
liver injury
signal transductionpathway